Literature DB >> 15788619

Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET.

Florian Dammann1, Marius Horger, Marcus Mueller-Berg, Heinz Schlemmer, Claus D Claussen, Claus Claussen, Juergen Hoffman, Susanne Eschmann, Roland Bares.   

Abstract

OBJECTIVE: We sought to evaluate the efficiency of (18)FDG PET, CT, and MRI for the preoperative staging of squamous cell carcinoma (SCC) of the head and neck region.
CONCLUSION: MRI is recommended as the method of choice in the preoperative evaluation of SCC of the oral cavity and the oropharynx. PET can provide relevant diagnostic information in case of equivocal findings by MRI or CT. Routine use of PET, however, does not appear to be necessary if optimized MRI is available.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15788619     DOI: 10.2214/ajr.184.4.01841326

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  29 in total

1.  Clinical evaluation of a newly developed method for avoiding artifacts caused by dental fillings on X-ray CT.

Authors:  Yasuo Nakae; Kiyoshi Sakamoto; Takahiro Minamoto; Toshiko Kamakura; Yuji Ogata; Mitsuhiro Matsumoto; Takeshi Johkou
Journal:  Radiol Phys Technol       Date:  2007-12-14

2.  Head and neck cancer: how imaging predicts treatment outcome.

Authors:  Robert Hermans
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

3.  Controversies: is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma?

Authors:  Suresh K Mukherji; Carol R Bradford
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

4.  FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.

Authors:  Voichita Bar-Ad; Wenyin Shi; Madalina Tuluc; Nitin Ohri; David Cognetti; Joseph Curry; Charles Intenso
Journal:  J Nucl Med Radiat Ther       Date:  2012-02-01

5.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

Review 6.  CT-MR integrated diagnostic imaging of the oral cavity: neoplastic disease.

Authors:  S Mazziotti; G Ascenti; E Scribano; A Mileto; S Racchiusa; C Visalli; I Salamone; S Vinci; A Blandino
Journal:  Radiol Med       Date:  2012-03-19       Impact factor: 3.469

7.  FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.

Authors:  Vasavi Paidpally; Alin Chirindel; Stella Lam; Nishant Agrawal; Harry Quon; Rathan M Subramaniam
Journal:  Imaging Med       Date:  2012-12

8.  Combined SPECT/CT improves detection of initial bone invasion and determination of resection margins in squamous cell carcinoma of the head and neck compared to conventional imaging modalities.

Authors:  A Kolk; T Schuster; A Chlebowski; P Lange; K Scheidhauer; M Kesting; O Bissinger; M Schwaiger; J Dinges; J Weitz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-27       Impact factor: 9.236

9.  Staging primary head and neck cancers with (18)F-FDG PET/CT: is intravenous contrast administration really necessary?

Authors:  Keisuke Yoshida; Akiko Suzuki; Toshiyuki Nagashima; Jin Lee; Choichi Horiuchi; Mamoru Tsukuda; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-08       Impact factor: 9.236

10.  Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer.

Authors:  Akram Al-Ibraheem; Andreas Buck; Bernd Joachim Krause; Klemens Scheidhauer; Markus Schwaiger
Journal:  J Oncol       Date:  2009-08-20       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.